United States Home Infusion Therapy Market Report by Application, Product, States and Company Analysis 2026-2034

United States Home Infusion Therapy Market Size & Forecast 2026-2034

The US home infusion therapy market has tremendous scope for growth, and its size is estimated to increase from US$ 23.53 billion in 2025 to US$ 43.84 billion in 2034, growing at a steady Compound Annual Growth Rate (CAGR) of 7.16% from 2026 to 2034. Factors such as increased demand for cost-effective treatments, a growing prevalence of chronic conditions, and advancements in portable infusion therapies are contributing to its growth. Furthermore, the shift in focus toward home-based healthcare and patient ease is also likely to boost this market during the forecast period.

United States Home Infusion Therapy Market Outlooks

Home infusion therapy is a medical therapy in which medications or fluids are infused into the patient's bloodstream through an intravenous or subcutaneous route while the patient is at home. The therapy is often given for antibiotics, chemotherapy, pain control, hydration, and nutritional support. The therapy is usually given to patients with chronic and acute conditions and provides them with hospital-level therapy while they are in a comfortable and familiar setting.

Home infusion therapy is very popular in the USA, and the popularity is growing day by day because of its convenience and cost-effectiveness, as well as its potential to reduce hospitalization. The cost of healthcare is rising, and the need to reduce hospitalization is becoming more important, and hence the popularity of home infusion therapy is growing in the country. Moreover, the aging factor and the increased incidence of chronic conditions, such as cancer, diabetes, and immune system disorders, are also contributing to the popularity of the therapy, as the therapy is preferred by the patients as well, as it provides them with an improved quality of life, reduces the risk of hospital-acquired infections, and provides them with independence.

Growth Drivers of the United States Home Infusion Therapy Market

Rising Prevalence of Chronic Diseases

Approximately 129 million people in the US are estimated to have at least 1 major chronic disease (heart disease, cancer, diabetes, obesity, hypertension) as classified by the US Department of Health and Human Services. Five of the top 10 causes of death in the US are, or are strongly linked with, preventable and treatable chronic diseases (3). Over the last 2 decades, the number of people with chronic diseases has risen steadily and is expected to continue doing so. More and more people in America are struggling with multiple chronic diseases: 42% of people are struggling with 2 or more chronic diseases, and 12% are struggling with at least 5 chronic diseases. Apart from the personal toll of chronic diseases, there is a significant impact on the health care system of the US as a whole. The growing problem of chronic diseases like cancer, diabetes, immune system diseases, and infections is a significant factor in the home infusion therapy market in the US. With an increase in age, the occurrence of such diseases will only keep rising, thereby increasing the demand for uninterrupted and hassle-free treatment options. With the help of home infusion therapy, patients do not have to visit hospitals frequently, thus ensuring quality treatment. Moreover, there has been an improvement in specialty drugs, which are administered through infusion therapy, thereby increasing the scope of treatment options at home. The increasing patient pool, along with the rising need to manage diseases, has contributed significantly towards increasing this market.

Cost Efficiency and Healthcare System Optimization

One of the most significant factors for growth is the cost-saving benefits of home infusion therapy over traditional hospital-based treatments. Inpatient care and prolonged hospitalizations can be costly for healthcare systems and individuals. Home infusion therapy minimizes this cost burden while maintaining treatment efficacy. Insurance companies and governments encourage home-based care systems to manage healthcare expenses. Moreover, home infusion therapy allows hospitals to manage patient volumes more effectively, enabling them to focus on more critical cases. The overall effectiveness of healthcare systems can be optimized with home infusion therapy. From an economic standpoint, home infusion therapy can be considered more beneficial than traditional treatments. It is for this reason that home infusion therapy is becoming increasingly popular in the United States. In this regard, it was announced in April 2024 that Baxter had received FDA clearance for its Novum IQ large volume infusion pump and Dose IQ safety software. It is an advancement in connected and intelligent infusion therapy systems for better patient safety and care.

Technological Advancements and Improved Patient Convenience

Innovation in technology has also been a vital factor in the advancement and use of home infusion therapy. Modern infusion pumps, user-friendly devices, and monitoring tools enable patients to receive treatments safely and effectively without requiring constant medical supervision. This has greatly improved patient satisfaction and quality of life, especially for those with physical limitations and those requiring long-term treatments. Patients can continue with their daily activities, avoiding stress associated with receiving treatments in a clinical setting, and experience a sense of independence and comfort in receiving treatments from the comfort of their own homes. As innovation in technology continues, it is believed that receiving treatments at home will be even more efficient and convenient. April 2025, ICU Medical cleared by FDA for new additions to its infusion pump portfolio, including the Plum Solo single-channel and updated Plum Duo dual-channel precision IV pumps.

Challenges of the United States Home Infusion Therapy Market

Reimbursement and Insurance Limitations

Despite its cost benefits, one of the main hurdles faced by home infusion therapy in terms of reimbursement in the US market is its coverage by different insurance providers, such as Medicare and Medicaid, and different private insurance providers, leading to a lack of uniformity in its use among patients. Further, in certain cases, a part of the therapy, such as medication, equipment, and nursing, might not be fully covered, leading to a cost burden on patients. This has resulted in a lack of encouragement for its use, especially among those who are less affluent. Although policy changes are introduced to improve coverage, there are still gaps, hindering its use and hence restricting its market growth in the coming years.

Risk of Complications and Need for Skilled Care

Home infusion therapy, though more convenient, has associated risks, including infection, catheter-related complications, and medication errors. The patients and caregivers, unlike healthcare professionals, might not possess adequate expertise, which makes proper training, education, and support essential in ensuring proper therapy. Moreover, there might be a shortage of skilled home healthcare nurses, making things more complicated. Patient compliance and side effects might be difficult to manage, especially since patients will be receiving therapy away from healthcare facilities. If there are complications, patients might be readmitted, thus eliminating the advantage of receiving therapy in a home setting. Patient safety, therefore, becomes crucial, including proper safety measures, equipment, and communication between patients and healthcare providers. All these factors, therefore, demonstrate the significance of proper risk mitigation, including workforce issues, in ensuring proper development in this market.

United States Endocrinology Market

The US market for endocrinology has been growing steadily, and this can be attributed to an increase in the prevalence rate of hormonal disorders, such as diabetes, thyroid disorders, and obesity. The awareness and screening levels for endocrine disorders are also contributing to a higher rate of treatments, leading to a growing endocrinology market in the US. The development of new technologies, such as continuous glucose monitoring and insulin pumps, has also improved the management and control of endocrine disorders, thus contributing to a growing US market for endocrinology. The population in the US has also been growing, and with age, the risk of developing endocrine disorders also increases, thus contributing to a growing endocrinology market in the US. The development of new pharmaceuticals, especially biologics and hormone therapies, has also contributed to a growing US market for endocrinology. The introduction of telemedicine has also improved patient accessibility to endocrinologists, especially in rural areas, and lifestyle, sedentary, and dietary habits are also contributing to a growing US market for endocrinology, as they are leading to an increased prevalence rate of endocrine disorders.

United States Chemotherapy Therapy Market

The United States chemotherapy therapy market is still witnessing growth due to an increase in the incidence rate of cancer and advances in oncology treatments. Chemotherapy is an essential part of cancer treatment, often used in combination with other treatments like targeted therapy, immunotherapy, and radiation. Advances in chemotherapy formulations and techniques have enhanced its efficacy and reduced side effects. The trend of chemotherapy treatment at home or through outpatient treatment centers is another factor for market growth. Increasing healthcare investments and high R&D activity are propelling the market for chemotherapeutic drugs. Moreover, an increased focus on personalized medicine is allowing for more individualized treatment approaches based on genetic and molecular profiling. Despite competition from other treatments, chemotherapy remains a popular treatment approach due to its proven efficacy in treating different forms of cancer. Increasing awareness, screening, and access to oncology treatment centers are supporting the continued growth of this market.

United States Parenteral Nutrition Therapy Market

The parenteral nutrition therapy market in the United States is growing due to an increase in the number of patients suffering from gastrointestinal disorders, malnutrition, and chronic illnesses, which affect nutrient absorption. Parenteral nutrition therapy helps patients receive essential nutrients directly into the bloodstream, and this has become a vital part of healthcare for those who cannot normally take and digest food. The growing incidence of diseases such as cancer, Crohn's disease, and short bowel syndrome has also contributed to parenteral nutrition therapy market growth. Furthermore, technological advancements in parenteral nutrition formulations and infusion devices have improved its safety and efficacy, and the growing trend of home-based healthcare has also contributed to parenteral nutrition therapy market growth in the United States. Parenteral nutrition therapy has also gained importance in the United States healthcare industry, and healthcare providers are increasingly focusing on developing personalized nutrition plans for patients, leading to parenteral nutrition therapy market growth in the United States.

United States Home Infusion Pump Market

The United States home infusion pump market is witnessing high growth due to the increasing need for home-based healthcare solutions. Infusion pumps are an essential part of healthcare solutions, especially when delivering medications to patients. These pumps are used in chemotherapy, antibiotic therapy, pain management, and other treatments. Infusion pumps are also used to administer medications to patients at home. These pumps are essential for delivering medications to patients at home. With the increasing need to provide healthcare solutions to patients at home, the home infusion pump market is witnessing high growth. Infusion pumps are also used to manage pain. Pain management is one of the essential treatments using infusion pumps. These pumps are also used to provide antibiotic therapy to patients. With the increasing need to provide healthcare solutions to patients at home, the home infusion pump market is witnessing high growth.

United States Home Infusion IV Cannulas Market

The United States home infusion IV cannulas market is growing steadily, and this growth can be attributed to the increasing demand for home-based intravenous therapies. IV cannulas play a vital role in ensuring vascular access for medication, fluid, and nutrient administration in a home setting. The growing prevalence of chronic conditions, an aging population, and a preference for minimally invasive treatments are contributing to the growth of the market. The development of improved technologies has resulted in safer, more comfortable, and longer-lasting cannulas, minimizing the risk of adverse effects such as infections and irritation of veins. Training and education for patients and caregivers also play a vital role in ensuring that they can administer treatments effectively and efficiently, thus contributing to the growth of the market. The expansion of home healthcare and healthcare policies also play a vital role in ensuring the growth of the market, and as more patients opt to receive treatments in a home setting, the demand for quality IV access devices such as cannulas is likely to continue growing in the United States.

California Home Infusion Therapy Market

The California market for home infusion therapy has been observed to be one of the largest in the US, considering its large population base, developed healthcare system, and increased use of home-based healthcare services. The large population base and prevalence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, among the aging population in California also play a vital role in contributing to the growth of the market. The healthcare system in California has also been observed to be one of the most developed, with a large number of healthcare providers and a growing use of advanced infusion therapies and telemedicine, allowing for efficient and remote management of patient conditions. The growing healthcare costs in hospitals have also forced patients and healthcare providers to seek alternatives in terms of cost-effectiveness and patient comfort, and home infusion therapies have been seen to fulfill this requirement, leading to a growing market in California.

New Jersey Home Infusion Therapy Market

The New Jersey home infusion therapy market has been witnessing steady growth, thanks to its well-developed healthcare infrastructure and proximity to major pharmaceutical and biotechnology centers. The state has a high concentration of specialized healthcare providers and skilled professionals, which has a positive impact on the quality and availability of home infusion therapy. The rising incidence of chronic diseases and an aging population are some of the major factors driving the demand for home infusion therapy in New Jersey. The state has a favorable insurance and reimbursement environment, which has contributed to the growth of home infusion therapy. Patients are increasingly seeking home infusion therapy, considering its convenience and reduced hospital visits. Technological advancements, including portable infusion devices and safety features, have added strength to this segment. The state's commitment to efficient healthcare delivery and patient satisfaction has been driving the growth of home infusion therapy services in both urban and suburban areas.

New York Home Infusion Therapy Market

The home infusion therapy market in New York is witnessing rapid growth, thanks to the presence of a large and diverse population, along with a high demand for quality healthcare services. The state has been facing a high burden of chronic diseases, and many patients are in need of long-term therapy, thus driving the demand for home infusion therapy. The presence of a strong healthcare infrastructure, including some of the best hospitals in the state, has helped in popularizing home infusion therapy. Moreover, the increasing use of digital technologies has contributed to the growth of the home infusion therapy market in New York. The urban population in particular has shown a positive inclination towards home care, considering factors such as reduced overcrowding in hospitals and healthcare costs. The reimbursement policies have been favorable, thus supporting the growth of the home infusion therapy market in New York. With increasing awareness, the home infusion therapy market in New York has been witnessing steady growth.

Washington Home Infusion Therapy Market

The Washington state home infusion therapy market is expanding at a steady rate due to the increasing need for home healthcare services and the high emphasis placed on innovative medical technologies. The healthcare system in Washington state is patient-centered, and this has encouraged the use of home infusion therapy to provide comfort to patients and reduce hospital stay. The rising incidence of chronic diseases and the aging population have also contributed to the need for long-term treatment solutions that can be administered at home. Washington state is also known to be at the forefront of embracing technology in healthcare, and this includes the use of telemedicine and remote monitoring technologies to provide safe and effective infusion therapy outside the hospital. Moreover, healthcare providers and insurance companies in Washington state are becoming more aware of the cost advantages of home infusion therapy. With the constant advancements in infusion technologies and healthcare policies, the market is expected to grow with more and more people embracing home infusion therapy.

United States Home Infusion Market Segments

Application

1. Anti-Infective

2. Endocrinology

3. Hydration Therapy

4. Chemotherapy

5. Enteral Nutrition

6. Parenteral Nutrition

7. Specialty Pharmaceuticals

8. Others

Product

1. Infusion Pumps

2. Intravenous Sets

3. IV Cannulas

4. Needleless Connectors

States

1. California

2. Texas

3. New York

4. Florida

5. Illinois

6. Pennsylvania

7. Ohio

8. Georgia

9. New Jersey

10. Washington

11. North Carolina

12. Massachusetts

13. Virginia

14. Michigan

15. Maryland

16. Colorado

17. Tennessee

18. Indiana

19. Arizona

20. Minnesota

21. Wisconsin

22. Missouri

23. Connecticut

24. South Carolina

25. Oregon

26. Louisiana

27. Alabama

28. Kentucky

29. Rest of United States

All companies have been covered with 5 Viewpoints

1. Overviews

2. Key Person

3. Recent Developments

4. SWOT Analysis

5. Revenue Analysis

Company Analysis:

1. Baxter International Inc.

2. Becton Dickinson and Company

3. Eli Lilly & Company

4. Fresenius SE & Co. KGaA

5. ICU Medical Inc.

6. Option Care Health Inc.

7. Terumo Corporation